Product Information
DICLOFENAC SODIUM 3% GEL is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3679 per GM under NDC 68462035594. Its NADAC has been published 520 times since Oct 19, 2016.
FDA first approved this application on Sep 13, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462035594
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208301FDA Approved
9/13/2016
TE Code
AB
On Market Since
9/13/2016
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC SODIUM 3% GEL has been published 520 times since Oct 19, 2016, and over the history we have for it it has declined 92.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3679 per GM |
|---|---|
| All-time high | $4.9084 (Feb 15, 2017) |
| All-time low | $0.3077 (Apr 17, 2024) |
| 52-week high | $0.3862 |
| 52-week low | $0.3573 |
| Median price | $0.4559 |
| Average price | $0.8637 |
| Largest weekly change | +46.5% (Aug 23, 2023) |
| Weeks tracked | 520 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC SODIUM 3% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC SODIUM 3% GEL, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3679 per GM (NDC 68462035594), effective Sep 30, 2026.
How has the price of DICLOFENAC SODIUM 3% GEL changed over time?
Over the history we have for it, the NADAC for DICLOFENAC SODIUM 3% GEL has declined 92.0%. It has been tracked across 520 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for DICLOFENAC SODIUM 3% GEL?
Since Oct 19, 2016, the NADAC for DICLOFENAC SODIUM 3% GEL has ranged from a low of $0.3077 (Apr 17, 2024) to a high of $4.9084 (Feb 15, 2017), with a median of $0.4559 per GM.
Are there cheaper alternatives to DICLOFENAC SODIUM 3% GEL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC SODIUM 3% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC SODIUM 3% GEL?
DICLOFENAC SODIUM 3% GEL (NDC 68462035594) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.